Related Experiment Video
Updated: May 25, 2026

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
An explorative analysis of secretory receptor for advanced glycation endproducts in primary focal segmental
Harin Rhee1, Sang Heon Song, Ihm Soo Kwak
1Division of Nephrology, Department of Internal Medicine, Pusan National University School of Medicine, 179 Gudeok-ro, Seo-gu, Busan 602-739, Republic of Korea.
Background:
Despite remarkable medical progress, the main pathogenetic mechanisms of focal segmental glomerulosclerosis (FSGS) have not been fully delineated and its prognosis is poor at present. Recently, it was revealed that the receptor for advanced glycation endproducts (RAGE) was highly expressed at the base of podocytes with an up-regulation mainly in diabetic nephropathy. However, there is no report about the association between glomerulonephritis and RAGE. The aims of the current study were to explore the relationships between several clinical parameters and circulating soluble RAGE in primary FSGS and compare serum levels in primary FSGS with immunoglobulin A nephropathy (IgAN) and controls.
Methods:
A total of 35 subjects aged >18 years were enrolled. Thirty-five subjects consisted of three groups: primary FSGS (N = 15), IgAN (N = 10), and normal controls (N = 10). Laboratory measurements of serum carboxymethyl-lysin (CML), soluble RAGE (sRAGE), and endogenous secretory RAGE (esRAGE) were performed.
Results:
Serum esRAGE level in the FSGS group was higher than that in the IgAN group (0.55 ± 0.32 ng/mL vs. 0.27 ± 0.11 ng/mL, p = 0.013). There was no statistical difference between sRAGE and CML among the three groups. Within the FSGS group, esRAGE, but not sRAGE, was positively correlated with 24-h urinary protein (r = 0.553, p = 0.033) and negatively correlated with body mass index (r = -0.623, p = 0.013). In stepwise multiple regression analysis, body mass index and 24-h urinary protein were significant contributors to esRAGE within the FSGS group.
Conclusion:
This study showed that only the serum level of esRAGE, not sRAGE, was higher in the FSGS group than in the IgAN and control groups. The amount of 24-h proteinuria was also related to the serum level of esRAGE in the FSGS group.
Insights
Endogenous secretory receptor for advanced glycation endproducts (esRAGE) levels were higher in focal segmental glomerulosclerosis (FSGS) patients compared to IgA nephropathy and controls. Higher esRAGE correlated with increased proteinuria in FSGS.
Area of Science:
- Nephrology
- Immunology
- Endocrinology
Background:
- Focal segmental glomerulosclerosis (FSGS) pathogenesis remains unclear, with poor prognosis.
- Receptor for advanced glycation endproducts (RAGE) is implicated in diabetic nephropathy but its role in glomerulonephritis is unexplored.
- Investigating RAGE in primary FSGS is crucial for understanding disease mechanisms.
Purpose of the Study:
- To explore the relationship between clinical parameters and soluble RAGE (sRAGE) in primary FSGS.
- To compare serum levels of sRAGE and its variants in primary FSGS, IgA nephropathy (IgAN), and healthy controls.
Main Methods:
- Serum levels of carboxymethyl-lysin (CML), sRAGE, and endogenous secretory RAGE (esRAGE) were measured.
- A cohort of 35 subjects was divided into primary FSGS (N=15), IgAN (N=10), and control (N=10) groups.
- Statistical analyses, including correlation and regression, were performed to assess relationships.
Main Results:
- Serum esRAGE levels were significantly higher in the FSGS group compared to the IgAN and control groups (p=0.013).
- No significant differences in sRAGE or CML levels were observed among the groups.
- Within the FSGS group, esRAGE positively correlated with 24-hour urinary protein (r=0.553, p=0.033) and negatively with BMI (r=-0.623, p=0.013).
Conclusions:
- Serum esRAGE, but not sRAGE, is elevated in primary FSGS patients.
- 24-hour proteinuria is a significant clinical parameter associated with serum esRAGE levels in FSGS.
- These findings suggest a potential role for esRAGE in FSGS pathophysiology.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Proteoglycans
Diabetic Nephropathy
